查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1678714

失眠治療市場規模、佔有率、趨勢分析報告：按類型、銷售管道、地區、細分市場預測，2025-2030 年

Insomnia Therapeutics Market Size, Share & Trends Analysis Report By Type (Benzodiazepines, Nonbenzodiazepines, Antidepressants, Orexin Antagonists, Melatonin Antagonists), By Sales Channel, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

失眠治療市場的成長與趨勢

根據 Grand View Research, Inc. 的一份新報告，全球失眠治療市場預計到 2030 年將達到 37.4 億美元，2025 年至 2030 年的複合年成長率為 4.5%。

市場主要受到取得專利的分子、潛在臨床候選藥物、不斷上升的壓力水平以及越來越多的老年人難以入睡的推動。失眠症盛行率的上升、人們對失眠症認知的提高以及更安全藥物的普及預計將推動收益成長。

據估計，失眠影響著全球約 35％ 的人口。失眠症有多種類型，包括入睡困難、睡眠維持困難，並且通常伴隨頻繁、過早醒來以及難以重新入睡。長期失眠會干擾您的日常生活並導致工作效率低下。如果不及時治療，這種情況會導致嚴重的憂鬱症和神經衰弱。

影響失眠治療市場成長的因素包括壓力水平的上升、市場上專利分子的存在、臨床管線中的潛在藥物、技術先進的醫療設備的引進以及老年人口的增加。人們越來越意識到睡眠不足對日常生活的影響，預計將增加各種失眠治療方法的採用，從而導致失眠治療市場的收益成長。

目前，治療失眠最廣泛使用的藥物包括非專利非苯二氮平類藥物和抗憂鬱症，市面上還有一些較新的藥物，如Orexin拮抗劑和褪黑激素拮抗劑。Eisai的 lemborexant 的推出預計將解決該領域尚未滿足的醫療需求，並在預測期內推動市場成長。根據2015年聯合國的報告，預計到2030年，60歲以上人口將增加56%，達到約14億。這些數據表明，老年人口正在增加。由於這一人群更容易受到睡眠不足的影響，對失眠治療的需求預計會增加。

失眠治療市場報告重點

  • 苯二氮平類藥物將佔據市場主導地位，到 2024 年的佔有率將達到 29.1%。苯二氮平類藥物可用於治療與急性壓力相關的失眠。預計抗憂鬱症在預測期內將顯著成長。
  • 非處方藥 (OTC) 將引領市場，到 2024 年將佔據 61.6% 的佔有率。由於人們對藥物及其消費的認知不斷提高，預計處方藥治療將在預測期內快速成長。
  • 北美失眠治療市場將在 2024 年佔據全球市場的主導地位，收益佔有率為 35.4%。該地區市場的成長歸因於該地區失眠盛行率的上升、意識層級的提高以及高昂的醫療支出。
  • 預計預測期內亞太地區失眠治療市場將實現最快的複合年成長率，為 5.3%。亞太地區失眠治療市場預計將見證失眠治療市場的顯著成長。

目錄

第1章調查方法與範圍

第 2 章執行摘要

3. 失眠治療市場變數、趨勢與範圍

  • 市場體系展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 商業環境分析
    • 產業分析 – 波特五力分析
    • PESTLE分析

第 4 章失眠治療市場：類型業務分析

  • 2024 年和 2030 年各類型的市場佔有率
  • 類型細分儀表板
  • 2018 年至 2030 年按類型分類的市場規模、預測與趨勢分析
  • 苯二氮平類
  • 非苯二氮平類
  • 抗憂鬱症
  • Orexin拮抗劑
  • 褪黑激素拮抗劑
  • 其他

第 5 章失眠治療市場：銷售管道業務分析

  • 2024 年及 2030 年銷售管道市場佔有率
  • 銷售管道細分儀表板
  • 2018 年至 2030 年按銷售管道分類的市場規模、預測與趨勢分析
  • 處方藥
  • 場外交易（OTC）

第6章 失眠治療市場：區域估計與趨勢分析

  • 2024 年及 2030 年區域市場佔有率分析
  • 區域市場儀表板
  • 市場規模、預測趨勢分析，2018-2030
  • 北美洲
    • 按國家/地區，2018 年至 2030 年
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 按國家/地區，2018 年至 2030 年
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 挪威
    • 丹麥
    • 瑞典
  • 亞太地區
    • 按國家/地區，2018 年至 2030 年
    • 日本
    • 中國
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 按國家/地區，2018 年至 2030 年
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 按國家/地區，2018 年至 2030 年
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭格局

  • 參與者概述
  • 企業市場分析
  • 公司分類
  • 戰略地圖
  • 公司簡介/上市公司
    • Takeda Pharmaceutical Company Limited
    • VANDA PHARMACEUTICALS
    • Merck & Co., Inc.
    • Pfizer Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Mylan NV（Viatris Inc.）
    • Sumitomo Pharma Co., Ltd.
    • Sanofi
    • Paratek Pharmaceuticals, Inc.
    • Ebb Therapeutics（Kryo）
Product Code: GVR-2-68038-213-6

Insomnia Therapeutics Market Growth & Trends:

The global insomnia therapeutics market size is expected to reach USD 3.74 billion by 2030, registering a CAGR of 4.5% from 2025 to 2030, according to a new report by Grand View Research, Inc. The market is primarily driven by the presence of patented molecules, potential clinical pipeline candidates, rising stress level, and increase in geriatric population who find it difficult to fall asleep. Increase in prevalence of insomnia & awareness about this condition and availability of safer drugs are anticipated to fuel revenue growth.

Insomnia is estimated to affect approximately 35% of the global population. Different patterns of the condition include difficulty in sleep initiation and maintenance, which is generally accompanied with frequent awakenings & awakening too early with trouble sleeping again. Long-term insomnia can hamper everyday life, which may result in nonproductive work hours. If left untreated, this condition may lead to severe depression and nervous breakdown of the patient.

Factors influencing insomnia therapeutics market growth include rising stress level, presence of patented molecules in the market, potential drugs in clinical pipeline, introduction of technologically advanced medical devices, and growing geriatric population. Growing awareness about the impact of sleep deprivation on everyday life is anticipated to increase adoption rate of various treatments for insomnia, which is expected to lead to revenue growth of the insomnia therapeutics market.

Currently, widely adopted treatment options for insomnia include generic nonbenzodiazepines and antidepressants even though other novel agents such as orexin antagonists and melatonin antagonists are available in the market. Launch of Eisai's Lemborexant is expected to cater to unmet medical needs in this segment and fuel growth of this market over the forecast period. According to United Nations (UN) report in 2015, population in the age group of 60 years and above is projected to grow by 56% and is expected to reach around 1.4 billion by 2030. These statistics indicate the growing geriatric population. Since this population base is more susceptible to sleep deprivation, the demand for insomnia therapeutics is anticipated to increase.

Insomnia Therapeutics Market Report Highlights:

  • Benzodiazepines dominated the market and accounted for a share of 29.1% in 2024. Benzodiazepines are useful for insomnia associated with acute stress. Antidepressants are expected to grow lucratively over the forecast period.
  • Over-the-counter (OTC) led the market and accounted for a share of 61.6% in 2024, owing to the increasing number of patients with insomnia. Prescription therapeutics are projected to grow rapidly over the forecast period, fueled by the increasing awareness regarding drugs and their consumption amongst people.
  • North America insomnia therapeutics market dominated the global market with a revenue share of 35.4% in 2024. Market growth in the region is due to the rising incidence of insomnia disorders, the increase in awareness levels, and high healthcare spending in this region.
  • Asia Pacific insomnia therapeutics market is expected to register the fastest CAGR of 5.3% in the forecast period. Asia Pacific insomnia therapeutics market is anticipated to witness significant growth in the insomnia therapeutics market.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Type
    • 1.2.2. Sales Channel
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Insomnia Therapeutics Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Insomnia Therapeutics Market: Type Business Analysis

  • 4.1. Type Market Share, 2024 & 2030
  • 4.2. Type Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 4.4. Benzodiazepines
    • 4.4.1. Benzodiazepines Market, 2018 - 2030 (USD Million)
  • 4.5. Nonbenzodiazepines
    • 4.5.1. Nonbenzodiazepines Market, 2018 - 2030 (USD Million)
  • 4.6. Antidepressants
    • 4.6.1. Antidepressants Market, 2018 - 2030 (USD Million)
  • 4.7. Orexin Antagonists
    • 4.7.1. Orexin Antagonists Market, 2018 - 2030 (USD Million)
  • 4.8. Melatonin Antagonists
    • 4.8.1. Melatonin Antagonists Market, 2018 - 2030 (USD Million)
  • 4.9. Others
    • 4.9.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Insomnia Therapeutics Market: Sales Channel Business Analysis

  • 5.1. Sales Channel Market Share, 2024 & 2030
  • 5.2. Sales Channel Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Sales Channel, 2018 to 2030 (USD Million)
  • 5.4. Prescription
    • 5.4.1. Prescription Market, 2018 - 2030 (USD Million)
  • 5.5. Over-the-Counter (OTC)
    • 5.5.1. Over-the-Counter (OTC) Market, 2018 - 2030 (USD Million)

Chapter 6. Insomnia Therapeutics Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Market Share Analysis, 2024 & 2030
  • 6.2. Regional Market Dashboard
  • 6.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.4. North America
    • 6.4.1. North America Insomnia Therapeutics Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.4.2. U.S.
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Regulatory Framework
      • 6.4.2.3. Competitive Insights
      • 6.4.2.4. U.S. Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. Canada
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Regulatory Framework
      • 6.4.3.3. Competitive Insights
      • 6.4.3.4. Canada Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. Mexico
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Regulatory Framework
      • 6.4.4.3. Competitive Insights
      • 6.4.4.4. Mexico Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Europe
    • 6.5.1. Europe Insomnia Therapeutics Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.5.2. UK
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Regulatory Framework
      • 6.5.2.3. Competitive Insights
      • 6.5.2.4. UK Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Germany
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Regulatory Framework
      • 6.5.3.3. Competitive Insights
      • 6.5.3.4. Germany Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.4. France
      • 6.5.4.1. Key Country Dynamics
      • 6.5.4.2. Regulatory Framework
      • 6.5.4.3. Competitive Insights
      • 6.5.4.4. France Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.5. Italy
      • 6.5.5.1. Key Country Dynamics
      • 6.5.5.2. Regulatory Framework
      • 6.5.5.3. Competitive Insights
      • 6.5.5.4. Italy Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.6. Spain
      • 6.5.6.1. Key Country Dynamics
      • 6.5.6.2. Regulatory Framework
      • 6.5.6.3. Competitive Insights
      • 6.5.6.4. Spain Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.7. Norway
      • 6.5.7.1. Key Country Dynamics
      • 6.5.7.2. Regulatory Framework
      • 6.5.7.3. Competitive Insights
      • 6.5.7.4. Norway Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.8. Denmark
      • 6.5.8.1. Key Country Dynamics
      • 6.5.8.2. Regulatory Framework
      • 6.5.8.3. Competitive Insights
      • 6.5.8.4. Denmark Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.5.9. Sweden
      • 6.5.9.1. Key Country Dynamics
      • 6.5.9.2. Regulatory Framework
      • 6.5.9.3. Competitive Insights
      • 6.5.9.4. Sweden Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Asia Pacific
    • 6.6.1. Asia Pacific Insomnia Therapeutics Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.6.2. Japan
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Regulatory Framework
      • 6.6.2.3. Competitive Insights
      • 6.6.2.4. Japan Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. China
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Regulatory Framework
      • 6.6.3.3. Competitive Insights
      • 6.6.3.4. China Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. India
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Regulatory Framework
      • 6.6.4.3. Competitive Insights
      • 6.6.4.4. India Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. South Korea
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Regulatory Framework
      • 6.6.5.3. Competitive Insights
      • 6.6.5.4. South Korea Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.6. Australia
      • 6.6.6.1. Key Country Dynamics
      • 6.6.6.2. Regulatory Framework
      • 6.6.6.3. Competitive Insights
      • 6.6.6.4. Australia Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.6.7. Thailand
      • 6.6.7.1. Key Country Dynamics
      • 6.6.7.2. Regulatory Framework
      • 6.6.7.3. Competitive Insights
      • 6.6.7.4. Thailand Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.7. Latin America
    • 6.7.1. Latin America Insomnia Therapeutics Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.7.2. Brazil
      • 6.7.2.1. Key Country Dynamics
      • 6.7.2.2. Regulatory Framework
      • 6.7.2.3. Competitive Insights
      • 6.7.2.4. Brazil Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.7.3. Argentina
      • 6.7.3.1. Key Country Dynamics
      • 6.7.3.2. Regulatory Framework
      • 6.7.3.3. Competitive Insights
      • 6.7.3.4. Argentina Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 6.8. MEA
    • 6.8.1. MEA Insomnia Therapeutics Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 6.8.2. South Africa
      • 6.8.2.1. Key Country Dynamics
      • 6.8.2.2. Regulatory Framework
      • 6.8.2.3. Competitive Insights
      • 6.8.2.4. South Africa Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.8.3. Saudi Arabia
      • 6.8.3.1. Key Country Dynamics
      • 6.8.3.2. Regulatory Framework
      • 6.8.3.3. Competitive Insights
      • 6.8.3.4. Saudi Arabia Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.8.4. UAE
      • 6.8.4.1. Key Country Dynamics
      • 6.8.4.2. Regulatory Framework
      • 6.8.4.3. Competitive Insights
      • 6.8.4.4. UAE Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 6.8.5. Kuwait
      • 6.8.5.1. Key Country Dynamics
      • 6.8.5.2. Regulatory Framework
      • 6.8.5.3. Competitive Insights
      • 6.8.5.4. Kuwait Insomnia Therapeutics Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Participant Overview
  • 7.2. Company Market Position Analysis
  • 7.3. Company Categorization
  • 7.4. Strategy Mapping
  • 7.5. Company Profiles/Listing
    • 7.5.1. Takeda Pharmaceutical Company Limited
      • 7.5.1.1. Overview
      • 7.5.1.2. Financial Performance
      • 7.5.1.3. Product Benchmarking
      • 7.5.1.4. Strategic Initiatives
    • 7.5.2. VANDA PHARMACEUTICALS
      • 7.5.2.1. Overview
      • 7.5.2.2. Financial Performance
      • 7.5.2.3. Product Benchmarking
      • 7.5.2.4. Strategic Initiatives
    • 7.5.3. Merck & Co., Inc.
      • 7.5.3.1. Overview
      • 7.5.3.2. Financial Performance
      • 7.5.3.3. Product Benchmarking
      • 7.5.3.4. Strategic Initiatives
    • 7.5.4. Pfizer Inc.
      • 7.5.4.1. Overview
      • 7.5.4.2. Financial Performance
      • 7.5.4.3. Product Benchmarking
      • 7.5.4.4. Strategic Initiatives
    • 7.5.5. Teva Pharmaceutical Industries Ltd.
      • 7.5.5.1. Overview
      • 7.5.5.2. Financial Performance
      • 7.5.5.3. Product Benchmarking
      • 7.5.5.4. Strategic Initiatives
    • 7.5.6. Mylan N.V. (Viatris Inc.)
      • 7.5.6.1. Overview
      • 7.5.6.2. Financial Performance
      • 7.5.6.3. Product Benchmarking
      • 7.5.6.4. Strategic Initiatives
    • 7.5.7. Sumitomo Pharma Co., Ltd.
      • 7.5.7.1. Overview
      • 7.5.7.2. Financial Performance
      • 7.5.7.3. Product Benchmarking
      • 7.5.7.4. Strategic Initiatives
    • 7.5.8. Sanofi
      • 7.5.8.1. Overview
      • 7.5.8.2. Financial Performance
      • 7.5.8.3. Product Benchmarking
      • 7.5.8.4. Strategic Initiatives
    • 7.5.9. Paratek Pharmaceuticals, Inc.
      • 7.5.9.1. Overview
      • 7.5.9.2. Financial Performance
      • 7.5.9.3. Product Benchmarking
      • 7.5.9.4. Strategic Initiatives
    • 7.5.10. Ebb Therapeutics (Kryo)
      • 7.5.10.1. Overview
      • 7.5.10.2. Financial Performance
      • 7.5.10.3. Product Benchmarking
      • 7.5.10.4. Strategic Initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. Global insomnia therapeutics market, by region, 2018 - 2030 (USD Million)
  • Table 4. Global insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 5. Global insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
  • Table 6. North America insomnia therapeutics market, by country, 2018 - 2030 (USD Million)
  • Table 7. North America insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 8. North America insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
  • Table 9. U.S. insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 10. U.S. Insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
  • Table 11. Canada insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 12. Canada insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
  • Table 13. Mexico insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 14. Mexico insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
  • Table 15. Europe insomnia therapeutics market, by country, 2018 - 2030 (USD Million)
  • Table 16. Europe insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 17. Europe insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
  • Table 18. UK insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 19. UK Insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
  • Table 20. Germany insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 21. Germany insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
  • Table 22. France insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 23. France Insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
  • Table 24. Italy insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 25. Italy insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
  • Table 26. Spain insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 27. Spain insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
  • Table 28. Norway insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 29. Norway Insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
  • Table 30. Denmark insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 31. Denmark insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
  • Table 32. Sweden insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 33. Sweden insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
  • Table 34. Asia Pacific insomnia therapeutics market, by country, 2018 - 2030 (USD Million)
  • Table 35. Asia Pacific insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 36. Asia Pacific insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
  • Table 37. Japan insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 38. Japan insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
  • Table 39. China insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 40. China insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
  • Table 41. India insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 42. India insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
  • Table 43. Australia insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 44. Australia insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
  • Table 45. South Korea insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 46. South Korea insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
  • Table 47. Thailand insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 48. Thailand insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
  • Table 49. Latin America insomnia therapeutics market, by country, 2018 - 2030 (USD Million)
  • Table 50. Latin America insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 51. Latin America insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
  • Table 52. Brazil insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 53. Brazil insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
  • Table 54. Argentina insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 55. Argentina insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
  • Table 56. Middle East & Africa Insomnia therapeutics market, by country, 2018 - 2030 (USD Million)
  • Table 57. Middle East & Africa insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 58. Middle East & Africa insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
  • Table 59. South Africa insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 60. South Africa insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
  • Table 61. Saudi Arabia insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 62. Saudi Arabia insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
  • Table 63. UAE insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 64. UAE insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)
  • Table 65. Kuwait insomnia therapeutics market, by type, 2018 - 2030 (USD Million)
  • Table 66. Kuwait insomnia therapeutics market, by sales channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Insomnia therapeutics market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Type and sales channel outlook (USD Million)
  • Fig. 10 Competitive landscape
  • Fig. 11 Insomnia therapeutics market dynamics
  • Fig. 12 Insomnia therapeutics market: Porter's five forces analysis
  • Fig. 13 Insomnia therapeutics market: PESTLE analysis
  • Fig. 14 Insomnia therapeutics market: Type segment dashboard
  • Fig. 15 Insomnia therapeutics market: Type market share analysis, 2024 & 2030
  • Fig. 16 Benzodiazepines market, 2018 - 2030 (USD Million)
  • Fig. 17 Nonbenzodiazepines market, 2018 - 2030 (USD Million)
  • Fig. 18 Antidepressants market, 2018 - 2030 (USD Million)
  • Fig. 19 Orexin antagonists market, 2018 - 2030 (USD Million)
  • Fig. 20 Melatonin antagonists market, 2018 - 2030 (USD Million)
  • Fig. 21 Others market, 2018 - 2030 (USD Million)
  • Fig. 22 Insomnia therapeutics market: Sales channel segment dashboard
  • Fig. 23 Insomnia therapeutics market: Sales channel market share analysis, 2024 & 2030
  • Fig. 24 Prescription market, 2018 - 2030 (USD Million)
  • Fig. 25 Over-the-counter (OTC) market, 2018 - 2030 (USD Million)
  • Fig. 26 Insomnia therapeutics market revenue, by region
  • Fig. 27 Regional marketplace: Key takeaways
  • Fig. 28 Regional marketplace: Key takeaways
  • Fig. 29 North America insomnia therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 30 U.S. country dynamics
  • Fig. 31 U.S. insomnia therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 32 Canada country dynamics
  • Fig. 33 Canada insomnia therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 34 Mexico country dynamics
  • Fig. 35 Mexico insomnia therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 36 Europe insomnia therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 37 UK country dynamics
  • Fig. 38 UK insomnia therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 39 Germany country dynamics
  • Fig. 40 Germany insomnia therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 41 France country dynamics
  • Fig. 42 France insomnia therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 43 Italy country dynamics
  • Fig. 44 Italy insomnia therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 45 Spain country dynamics
  • Fig. 46 Spain insomnia therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 47 Norway country dynamics
  • Fig. 48 Norway insomnia therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 49 Sweden country dynamics
  • Fig. 50 Sweden insomnia therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 51 Denmark country dynamics
  • Fig. 52 Denmark insomnia therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 53 Asia Pacific insomnia therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 54 Japan country dynamics
  • Fig. 55 Japan insomnia therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 56 China country dynamics
  • Fig. 57 China insomnia therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 58 India country dynamics
  • Fig. 59 India insomnia therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 60 Australia country dynamics
  • Fig. 61 Australia insomnia therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 62 South Korea country dynamics
  • Fig. 63 South Korea insomnia therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 64 Thailand country dynamics
  • Fig. 65 Thailand insomnia therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 66 Latin America insomnia therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 67 Brazil country dynamics
  • Fig. 68 Brazil insomnia therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 69 Argentina country dynamics
  • Fig. 70 Argentina insomnia therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 71 MEA insomnia therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 72 South Africa country dynamics
  • Fig. 73 South Africa insomnia therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 74 Saudi Arabia country dynamics
  • Fig. 75 Saudi Arabia insomnia therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 76 UAE country dynamics
  • Fig. 77 UAE insomnia therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 78 Kuwait country dynamics
  • Fig. 79 Kuwait insomnia therapeutics market, 2018 - 2030 (USD Million)
  • Fig. 80 Company categorization
  • Fig. 81 Company market position analysis
  • Fig. 82 Strategic framework